Literature DB >> 29042987

Upregulation of Yes-associated protein and transcriptional co-activator with PDZ-binding motif influences the behavior of LOVO human colon adenocarcinoma cells.

Yu Li1, Lan Li1, Min Zhu1, Limin Ye1, Qian Yang1.   

Abstract

The present study aimed to investigate the role of Yes-associated protein (YAP) and transcriptional co-activator with PDZ-binding motif (TAZ) in the LOVO human colon adenocarcinoma cell line and explore the underlying mechanisms. First, the expression levels of YAP and TAZ were detected in LOVO cells using reverse-transcription quantitative PCR, and the results suggested that YAP and TAZ were faintly expressed in LOVO cells. To investigate the exact role of YAP and TAZ in LOVO cells, stable YAP- and/or TAZ-overexpressing LOVO cell lines were established using YAP and/or TAZ expression plasmids. An MTT assay and flow cytometry were used to assess cell proliferation and apoptosis, respectively. The results indicated that compared with the control, YAP or TAZ overexpression significantly increased the proliferation ability of LOVO cells, while apoptosis was significantly decreased. Furthermore, the expression of the tumor-associated proteins connective tissue growth factor and cysteine-rich angiogenic inducer 61, which have critical roles in facilitating cancer cell proliferation, migration and invasion, were found to be upregulated following upregulation of YAP and TAZ. In addition, the expression of cell apoptosis-associated protein B-cell lymphoma 2 (Bcl-2) was significantly increased, while Bcl-2-associated X protein and caspase-3 were inhibited by YAP or TAZ overexpression. All of these effects were amplified when YAP and TAZ were co-overexpressed. In conclusion, YAP and TAZ function as tumor promoters in human colon carcinoma, and upregulation of YAP and TAZ influences the behavior of LOVO colon adenocarcinoma cells via regulating tumor-associated gene expression.

Entities:  

Keywords:  TAZ; YAP; apoptosis; human colorectal carcinoma; proliferation

Year:  2017        PMID: 29042987      PMCID: PMC5639388          DOI: 10.3892/etm.2017.4962

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  28 in total

1.  Yes-associated protein promotes tumour development in luminal epithelial derived breast cancer.

Authors:  Xiaodan Wang; Lili Su; Qishui Ou
Journal:  Eur J Cancer       Date:  2011-11-05       Impact factor: 9.162

2.  Overexpression of yes-associated protein contributes to progression and poor prognosis of non-small-cell lung cancer.

Authors:  Yang Wang; Qianze Dong; Qingfu Zhang; Zixuan Li; Enhua Wang; Xueshan Qiu
Journal:  Cancer Sci       Date:  2010-01-23       Impact factor: 6.716

Review 3.  KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer.

Authors:  Wendy De Roock; Veerle De Vriendt; Nicola Normanno; Fortunato Ciardiello; Sabine Tejpar
Journal:  Lancet Oncol       Date:  2010-12-14       Impact factor: 41.316

Review 4.  The Hippo pathway in biological control and cancer development.

Authors:  Siew Wee Chan; Chun Jye Lim; Liming Chen; Yaan Fun Chong; Caixia Huang; Haiwei Song; Wanjin Hong
Journal:  J Cell Physiol       Date:  2011-04       Impact factor: 6.384

5.  YAP1 increases organ size and expands undifferentiated progenitor cells.

Authors:  Fernando D Camargo; Sumita Gokhale; Jonathan B Johnnidis; Dongdong Fu; George W Bell; Rudolf Jaenisch; Thijn R Brummelkamp
Journal:  Curr Biol       Date:  2007-11-01       Impact factor: 10.834

6.  TEAD mediates YAP-dependent gene induction and growth control.

Authors:  Bin Zhao; Xin Ye; Jindan Yu; Li Li; Weiquan Li; Siming Li; Jianjun Yu; Jiandie D Lin; Cun-Yu Wang; Arul M Chinnaiyan; Zhi-Chun Lai; Kun-Liang Guan
Journal:  Genes Dev       Date:  2008-06-25       Impact factor: 11.361

7.  Elucidation of a universal size-control mechanism in Drosophila and mammals.

Authors:  Jixin Dong; Georg Feldmann; Jianbin Huang; Shian Wu; Nailing Zhang; Sarah A Comerford; Mariana F Gayyed; Robert A Anders; Anirban Maitra; Duojia Pan
Journal:  Cell       Date:  2007-09-21       Impact factor: 41.582

8.  Clinical and prognostic significance of Yes-associated protein in colorectal cancer.

Authors:  Yan Wang; Chengyao Xie; Qingchang Li; Ke Xu; Enhua Wang
Journal:  Tumour Biol       Date:  2013-04-05

Review 9.  The hippo signaling pathway in development and cancer.

Authors:  Duojia Pan
Journal:  Dev Cell       Date:  2010-10-19       Impact factor: 12.270

10.  Overexpression of YAP and TAZ is an independent predictor of prognosis in colorectal cancer and related to the proliferation and metastasis of colon cancer cells.

Authors:  Lijuan Wang; Shengjia Shi; Zhangyan Guo; Xiang Zhang; Suxia Han; Angang Yang; Weihong Wen; Qing Zhu
Journal:  PLoS One       Date:  2013-06-10       Impact factor: 3.240

View more
  1 in total

Review 1.  Context-dependent roles of YAP/TAZ in stem cell fates and cancer.

Authors:  Lucy LeBlanc; Nereida Ramirez; Jonghwan Kim
Journal:  Cell Mol Life Sci       Date:  2021-02-13       Impact factor: 9.261

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.